Wednesday, June 15, 2016 4:11:43 PM
Bob
Recent TXG News
- 10x Genomics to Present at the BofA Securities 2024 Healthcare Conference • PR Newswire (US) • 05/02/2024 08:05:00 PM
- 10x Genomics Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/30/2024 08:05:00 PM
- 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 • PR Newswire (US) • 04/10/2024 08:05:00 PM
- 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay • PR Newswire (US) • 03/26/2024 01:00:00 PM
- 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel • PR Newswire (US) • 03/21/2024 08:05:00 PM
- 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products • PR Newswire (US) • 03/13/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:12:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:40:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:13:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:12:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:12:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 12:19:58 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 12:06:30 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:59:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:20:30 PM
- 10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference • PR Newswire (US) • 02/20/2024 09:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/15/2024 10:33:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 10:16:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:05:40 PM
- 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024 • PR Newswire (US) • 02/15/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:56:40 PM
- 10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology • PR Newswire (US) • 02/07/2024 09:05:00 PM
- 10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting • PR Newswire (US) • 02/05/2024 09:05:00 PM
- 10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 • PR Newswire (US) • 01/24/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:49:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM